Calvert et al
22
| Not stated | 6 months | Primary | Medication adherence | Self-report; MMAS-4; PDC | 4 |
Cossette et al
23
| Not stated | 6 weeks | Secondary | Cardiac rehab attendance | MMAS-4 | 3 |
Costa e Silva et al
24
| Yes | 6 months | Primary (one of) | Clinical improvement index (including medication adherence) | Self-report | 2 |
Du et al
25
| Not stated | 36 months | Secondary | Mortality and MACE | MMAS-4 | 6 |
Giallauria et al
26
| Not stated | 24 months | Secondary | Cardiopulmonary parameters and cardiovascular risk profile (including medication adherence) | Self-report | 24 |
Giannuzzi et al
27
| Yes | 36 months | Secondary | MACE | Self-report | 11 |
Gould28
| Not stated | 3 days | Primary (one of) | Medication adherence, use of urgent care, patient satisfaction and illness perceptions | MMAS-4 | 1 |
Gujral et al
29
| Not stated | 12 months | Primary (one of) | Medication adherence and treatment beliefs | MARS; MPR | 2 |
Ho et al
30
| Yes | 12 months | Primary | Medication adherence | PDC | 4 |
Jalal et al
32
| Not stated | 6 months | Primary | Medication adherence | MMAS-8 | 1 |
Jorstad et al
31
| Not stated | 12 months | Secondary | Lifestyle and biometric targets | Self-report | 4 |
Kotowycz et al
33
| Yes | 6 weeks | Secondary | MACE | Self-report | 4 |
Kronish et al
34
| Yes | 6 months | Primary (one of) | Adherence to medication, heart healthy diet, regular exercise and smoking cessation | Self-report | NR |
Lapointe et al
35
| Not stated | 18 months | Secondary | LDL-C targets | Prescription refills | NR |
Miller et al
36
| Not stated | 60 days | Primary | MRA | HBS | 3 |
Miller et al
37
| Not stated | 12 months | Primary | MRA | HBS | 3 |
Miller et al
38
| Not stated | 24 months | Primary | MRA | HBS | 3 |
Muñiz et al
39
| Not stated | 6 months | Primary (one of) | Behavioural and clinical targets (including medication adherence) | Self-report | 2 |
Najafi et al
40
| Not stated | 3 months | Primary | Medication adherence | MMAS-8 | 6 |
Polack et al
41
| Not stated | 6 weeks | Primary (one of) | Medication adherence and knowledge retention | MMAS-4 | 2 |
Polsook et al
42
| Not stated | 4 weeks | Primary (one of) | Medication adherence and self-efficacy | Pill count | 14 |
Redfern et al
43
| Yes | 3 months | Secondary | Behavioural and clinical targets | Self-report | 5 |
Redfern et al
44
| Yes | 12 months | Secondary | Behavioural and clinical targets | Self-report | 5 |
Uysal and Ozcan45
| Not stated | 3 months | Primary (one of) | Physical activity, medication adherence, anginal symptoms | MMAS-4 | 3 |
Xavier et al
46
| Yes | 12 months | Primary | Medication adherence | CMAS | 18 |
Sharma et al
47
| Yes | 24 months | Primary | Mediation adherence | CMAS | 10 |
Yorio et al
48
| Not stated | 12 months | Secondary | Improved LDL-C profile | Prescription refills | 1 |